SAM #36C10B26Q0804

VA award for Radformation radiotherapy QA SaaS system and repository

The Department of Veterans Affairs awarded Radformation, Inc. a contract for an enterprise-wide radiotherapy quality assurance system for VA cancer treatment centers. - Government buyer: Department of Veterans Affairs (VA), Veterans Health Administration (VHA), Technology Acquisition Center, supporting the National Radiation Oncology Program. - Awardee and solution provider: Radformation, Inc. No specific product model, part number, or quantity is identified. - What is being procured: A commercial off-the-shelf, online, vendor-agnostic radiotherapy technical quality assurance (QA) software-as-a-service (SaaS) system and repository to centralize and automate QA data collection, analysis, and reporting across VA Radiation Oncology Centers. - Supports linear accelerators; brachytherapy and other non-linear-accelerator teletherapy systems; diagnostic and radiotherapy imaging and positioning systems; and QA devices from diverse vendors. - Must meet applicable AAPM TG-142, TG-51, and TG-198 guidance, Medical Physics Practice Guidelines, and protocols. - Award value: $2,274,939.55. - Performance structure: A 12-month base period, four 12-month option periods, and one optional task; potential period of performance is up to 60 months.

Description

On September 29, 2026, the Department of Veterans Affairs (VA) Technology Acquisitions Center (TAC) in support of the Veterans Health Administration (VHA), National Radiation Oncology Program, awarded a Firm Fixed Price contract to Radformation, Inc., 261 Madison Avenue New York, NY 10016, for an Enterprise-wide Radiotherapy Technical Quality Assurance (QA) System and Repository. The contract will provide a Commercial Off-The-Shelf (COTS) online, vendor-agnostic, enterprise-wide Software as a Service (SaaS) Radiotherapy Quality Assurance (QA) solution that standardizes, automates, and centralizes treatment delivery device QA data acquisition, analysis, and reporting across all VA Radiation Oncology Centers. The solution will streamline quality monitoring of linear accelerators (linacs) and other radiation treatment devices, including, but not limited to, brachytherapy and other non-linac teletherapy systems; imaging systems, including diagnostic systems such as computed tomography (CT) and magnetic resonance imaging (MRI) devices, as well as on-board imaging and other radiotherapy positioning verification and monitoring systems; and QA devices across diverse vendors. The solution shall comply with the applicable requirements of the American Association of Physicists in Medicine (AAPM) Task Group (TG)-142, TG-51, TG-198, as well as Medical Physics Practice Guidelines (MPPG) and Protocols. The period of performance shall consist of a 12-month base period, with four 12-month option periods.

View original listing